Reuters -- An Irish court has ruled that a key patent protecting GlaxoSmithKline’s biggest-selling medicine is invalid, the British-based drugmaker said on Friday.
Reuters -- An Irish court has ruled that a key patent protecting GlaxoSmithKline’s biggest-selling medicine is invalid, the British-based drugmaker said on Friday.
